Mariano Guardado Estrada

Dr. Mariano Guardado Estrada


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2025 in Biomolecules
Verified
Journal Article
Open access
PDF file
Itzae Adonai Gutiérrez HurtadoItzae Adonai Gutiérrez Hurtado
Itzae Adonai Gutiérrez Hurtado
MGMayra Elizabeth García-Acéves
Mayra Elizabeth García-Acéves
YCYolanda Puga Carrillo
Yolanda Puga Carrillo
MEMariano Guardado Estrada
Mariano Guardado Estrada
DLDenisse Stephania Becerra Loaiza
Denisse Stephania Becerra Loaiza
José Alonso Aguilar-VelázquezJosé Alonso Aguilar-Velázquez
José Alonso Aguilar-Velázquez
Forensic genetics has experienced remarkable advancements over the past decades, evolving from the analysis of a limited number of DNA segments to comprehensive genome-wide investigations. This progression has significantly improved the ability to establish genetic profiles under diverse conditions and scenarios. Beyond individual identification, forensic genetics now enables the inference of physical traits (e.g., eye, hair, and skin color, as well as body composition), biogeographic ancestry, lifestyle habits such as alcohol and tobacco use, and even the transfer of genital microbiomes post-coitus, among other characteristics. Emerging trends point to a future shaped by the integration of cutting-edge technologies, including CRISPR-Cas systems, artificial intelligence, and machine learning, which promise to further revolutionize the field. This review provides a thorough exploration of forensic genetics, tracing its evolution from its foundational methods (past) to its diverse modern applications (present) and offering insights into its potential future directions.

1 February 2020 in Psychiatry Research
Verified
Journal Article
Closed access
CRClaudia González Ramírez
Claudia González Ramírez
AQAlexa Villavicencio Queijeiro
Alexa Villavicencio Queijeiro
SMSilvia Jiménez Morales
Silvia Jiménez Morales
DLDiego Bárcenas López
Diego Bárcenas López
AMAlfredo Hidalgo Miranda
Alfredo Hidalgo Miranda
MEMariano Guardado Estrada
Mariano Guardado Estrada

9 February 2016 in Clinical Genetics
Verified
Journal Article
Closed access
PDF file
MOMiguel Angel Alcántara Ortigoza
Miguel Angel Alcántara Ortigoza
BTBenilde Garcia de Teresa
Benilde Garcia de Teresa
AAAriadna González-del Angel
Ariadna González-del Angel
JBJaime Berumen
Jaime Berumen
MEMariano Guardado Estrada
Mariano Guardado Estrada
RRRocio Rius
Rocio Rius

8 September 2020 in Genes
Verified
Journal Article
Open access
PDF file
Gabriela Figueroa-GonzálezGabriela Figueroa-González
Gabriela Figueroa-González
JCJose Carrillo
Jose Carrillo
IPItzel Perez-Rodriguez
Itzel Perez-Rodriguez
DLDavid Cantú De León
David Cantú De León
Alma D. Campos-ParraAlma D. Campos-Parra
Alma D. Campos-Parra
Carlos Pérez-PlasenciaCarlos Pérez-Plasencia
Carlos Pérez-Plasencia
Background: Serine Threonine Kinase 11 (STK11), also known as LKB1, is a tumor suppressor gene that regulates several biological processes such as apoptosis, energetic metabolism, proliferation, invasion, and migration. During malignant progression, different types of cancer inhibit STK11 function by mutation or epigenetic inactivation. In Head and Neck Cancer, it is unclear what mechanism is involved in decreasing STK11 levels. Thus, the present work aims to determine whether STK11 expression might be regulated through epigenetic or post-translational mechanisms. Methods: Expression levels and methylation status for STK11 were analyzed in 59 cases of head and neck cancer and 10 healthy tissue counterparts. Afterward, we sought to identify candidate miRNAs exerting post-transcriptional regulation of STK11. Then, we assessed a luciferase gene reporter assay to know if miRNAs directly target STK11 mRNA. The expression levels of the clinical significance of mir-100-3p, -5p, and STK11 in 495 HNC specimens obtained from the TCGA database were further analyzed. Finally, the Kaplan–Meier method was used to estimate the prognostic significance of the miRNAs for Overall Survival, and survival curves were compared through the log-rank test. Results: STK11 was under-expressed, and its promoter region was demethylated or partially methylated. miR-17-5p, miR-106a-5p, miR-100-3p, and miR-100-5p could be negative regulators of STK11. Our experimental data suggested evidence that miR-100-3p and -5p were over-expressed in analyzed tumor patient samples. Luciferase gene reporter assay experiments showed that miR-100-3p targets and down-regulates STK11 mRNA directly. With respect to overall survival, STK11 expression level was significant for predicting clinical outcomes. Conclusion: This is, to our knowledge, the first report of miR-100-3p targeting STK11 in HNC. Together, these findings may support the importance of regulation of STK11 through post-transcriptional regulation in HNC and the possible contribution to the carcinogenesis process in this neoplasia.

27 April 2021 in PeerJ
Verified
Journal Article
Open access
PDF file
VMVanessa Martínez-Rivera
Vanessa Martínez-Rivera
CCChristian A. Cárdenas-Monroy
Christian A. Cárdenas-Monroy
OMOliver Millan-Catalan
Oliver Millan-Catalan
JGJessica González-Corona
Jessica González-Corona
NHN. Sofia Huerta-Pacheco
N. Sofia Huerta-Pacheco
MEMariano Guardado Estrada
Mariano Guardado Estrada
Background: The post-mortem interval (PMI) is the time elapsed since the dead of an individual until the body is found, which is relevant for forensic purposes. The miRNAs regulate the expression of some genes; and due to their small size, they can better support degradation, which makes them suitable for forensic analysis. In the present work, we evaluated the gene expression of miR-381-3p, miR-23b-3p, and miR-144-3p in skeletal muscle in a murine model at the early PMI. Methods: We designed a rat model to evaluate the early PMI under controlled conditions. This model consisted in 25 rats divided into five groups of rats, that correspond to the 0, 3, 6, 12 and 24 hours of PMI. The 0 h-PMI was considered as the control group. Muscle samples were taken from each rat to analyze the expression of miR-381-3p, miR-23b-3p, and miR-144-3p by quantitative RT-PCR. The gene expression of each miRNA was expressed as Fold Change (FC) and compared among groups. To find the targets of these miRNAs and the pathways where they participate, we performed an in-silico analysis. From the gene targets of miR-381-3p identified in the silico analysis, the EPC1 gene was selected for gene expression analysis by quantitative RT-PCR in these samples. Also, to evaluate if miR-381-3p could predict the early PMI, a mixed effects model was calculated using its gene expression. Results: An upregulation of miR-381-3p was found at 24 h-PMI compared with the control group of 0 h-PMI and (FC = 1.02 vs. FC = 1.96; p = 0.0079). This was the opposite for miR-23b-3p, which had a down-regulation at 24 h-PMI compared to 0 h-PMI (FC = 1.22 vs. FC = 0.13; p = 0.0079). Moreover, the gene expression of miR-381-3p increased throughout the first 24 h of PMI, contrary to miR-23b-3p. The targets of these two miRNAs, participate in biological pathways related to hypoxia, apoptosis, and RNA metabolism. The gene expression of EPC1 was found downregulated at 3 and 12 h of PMI, whereas it remained unchanged at 6 h and 24 h of PMI. Using a multivariate analysis, it was possible to predict the FC of miR-381-3p of all but 6 h-PMI analyzed PMIs. Discussion: The present results suggest that miR-23b-3p and miR-381-3p participate at the early PMI, probably regulating the expression of some genes related to the autolysis process as EPC1 gene. Although the miR-381-3p gene expression is a potential estimator of PMI, further studies will be required to obtain better estimates.

7 June 2023 in PeerJ
Verified
Journal Article
Open access
PDF file
MEMariano Guardado Estrada
Mariano Guardado Estrada
CCChristian A. Cárdenas-Monroy
Christian A. Cárdenas-Monroy
VMVanessa Martínez-Rivera
Vanessa Martínez-Rivera
FCFernanda Cortez
Fernanda Cortez
CPCarlos Pedraza-Lara
Carlos Pedraza-Lara
CPCarlos Pérez-Plasencia
Carlos Pérez-Plasencia
The postmortem interval (PMI) is the time elapsing since the death of an individual until the body is examined. Different molecules have been analyzed to better estimate the PMI with variable results. The miRNAs draw attention in the forensic field to estimate the PMI as they can better support degradation. In the present work, we analyzed the miRNome at early PMI in rats’ skeletal muscle using the Affymetrix GeneChip™ miRNA 4.0 microarrays. We found 156 dysregulated miRNAs in rats’ skeletal muscle at 24 h of PMI, out of which 84 were downregulated, and 72 upregulated. The miRNA most significantly downregulated was miR-139-5p (FC = −160, p = 9.97 × 10−11), while the most upregulated was rno-miR-92b-5p (FC = 241.18, p = 2.39 × 10−6). Regarding the targets of these dysregulated miRNAs, the rno-miR-125b-5p and rno-miR-138-5p were the miRNAs with more mRNA targets. The mRNA targets that we found in the present study participate in several biological processes such as interleukin secretion regulation, translation regulation, cell growth, or low oxygen response. In addition, we found a downregulation of SIRT1 mRNA and an upregulation of TGFBR2 mRNA at 24 h of PMI. These results suggest there is an active participation of miRNAs at early PMI which could be further explored to identify potential biomarkers for PMI estimation.